CD40 ligand gene and Kawasaki disease
Yoshihiro Onouchi(RIKEN Center for Integrative Medical Sciences), Akira Hata(Chiba University), Mayumi Tamari(Jikei University School of Medicine), Hiroyuki Aotsuka(Chiba Hospital), Tsutomu Saji, Yoichi Kaburagi(Seirei Social Welfare Community), Fumiyo Kudo(Boston Children's Hospital), Fumio Kishi(Sanyo (Japan)), Kunihiro Hamamoto(Fukuoka International University), Akiyoshi Nariai(Shimane Prefectural Central Hospital), Yoshimitsu Fukushima(Saitama Children's Medical Center), Yoshitake Sato(Subaru (Japan)), Yusuke Nakamura(Rissho University), Mayumi Yashiro, Tomisaku Kawasaki(Kurume University), Kazunobu Ouchi(Kawasaki Medical School), Yoshikazu Nakamura(Jichi Medical University), Keiko Wakui(Shinshu University), Sakura Onoue, Masaru Miura(Tokyo Metropolitan Children's Medical Center), Hiroshi Yanagawa(Keio University), Masaru Terai(Chiba University)
Cited by 67
Related Papers
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
|Circulation|2017|3.7k
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy
|Nature|1998|804